Clariant stock: Bernstein holds CHF 10.20 target ahead of results
Published on 10/30/2026 at 18:33 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWSAnalyst view meets reporting checkpoint
- Bernstein retained a Hold rating on Clariant ahead of the company’s third-quarter update.
- Clariant is scheduled to publish its third-quarter results on November 3, giving investors a fresh operating checkpoint.
- Management’s full-year outlook calls for broadly flat sales in local currency and an EBITDA margin of around 18 percent before exceptional items.
Bernstein kept its Hold rating on Clariant and a CHF 10.20 price target in a report dated October 14, according to Markets Insider. The analyst view comes as the specialty chemicals group approaches its third-quarter reporting date.
Clariant stock traded at 11.01 euros on Lang & Schwarz at 6:28:39 p.m. CEST on Friday, October 30, 3.17 percent below the Xetra close of Thursday, October 29, at 11.37 euros. The real-time quote of Clariant stock reflects the German trading reference, while Bernstein’s target is denominated in Swiss francs on the company’s home market.
Results will test the outlook
Clariant is scheduled to report third-quarter results on November 3. The release will give investors a new read on demand, pricing and the performance of its three business units: Care Chemicals, Catalysts and Adsorbents and Additives.
For the first half of 2026, Clariant reported sales of CHF 1.859 billion. Reported EBITDA rose to CHF 300 million, lifting the reported margin to 16.10 percent. EBITDA before exceptional items stood at CHF 331 million, corresponding to a margin of 17.80 percent.
Management has kept its 2026 outlook unchanged. It expects sales to remain broadly flat in local currency compared with 2025 and forecasts an EBITDA margin of around 18 percent before exceptional items. Catalysts remains the main operational pressure point, while Care Chemicals and Adsorbents and Additives have provided support.
Analyst target remains close
Bernstein’s CHF 10.20 target sits close to the latest Swiss quotation cited in the analyst report. The rating therefore leaves the November results as the next concrete test of whether operating progress can support the current market assessment.
Clariant’s investor-relations page describes the group as a specialty chemicals company focused on sustainability, innovation and three core business units. Its medium-term targets include annual sales growth of 4 to 6 percent and an EBITDA margin of 19 to 21 percent by 2027 at the latest. Clariant investor relations provides the company’s strategic framework.
European markets remain the relevant backdrop for Swiss equities. Current market reports track the wider market environment.
More news and analyses on Clariant stock will follow the company’s next reporting checkpoint.
Clariant stock at a glance
- Company: Clariant AG
- ISIN: CH0012142631
- Home listing: SIX Swiss Exchange
- Lang & Schwarz quote: 11.01 euros on October 30, 2026 at 6:28:39 p.m. CEST
- Daily comparison: 3.17 percent below the Xetra close of 11.37 euros on October 29, 2026
- Analyst view: Bernstein Hold rating and CHF 10.20 target
- Next report: November 3, 2026
- Sector: Specialty chemicals
